NO.
6-2/2002-DC
Directorate General of Health Services
(Drugs Control Section)
RE-REGISTRATION APPLICATION RECEIVED
|
S.NO. |
Date of Receipt |
Name Of Applicant(Indian Auth. Agent) |
Name and Address of Foreign Manf. |
Amount Recd.(In US$) |
Name(s) Of Drug |
| 1 |
10/3/2005 |
M/s. Esschem Pvt. Ltd., Mumbai |
M/s. Recorddati S.p.A, Italy |
US$7500 |
|
| 2 |
10/3/2005 |
M/s. Esschem Pvt. Ltd., Mumbai |
M/s. Recordeti Eshava, Spain |
US$3500 |
|
| 3. | 15/3/2005 | M/s. KEBEE PHARMACHEMIE PVT. LTD | M/s. SIFAVITOR, ITALY | US$14500 |
13. AMITRIPTYLINE HCL
|
| 3 |
21/3/2005 |
M/s. VHB Life Sciences Ltd., Mumbai |
M/s. Hulee Provinicial Bafeng Pharmaceuticals & Chemical Share Co., China |
US$13500 |
|
| 4 |
22/3/2005 |
M/s. Fulford (P) Ltd., Mumbai |
M/s. Schering Plough Ltd., Singapore |
US$2500 |
|
| 5 |
24/3/2005 |
M/s. Glaxo Smithkline Ltd., Mumbai |
M/s. Glaxo Smithkline, Belgium |
US$2500 |
|
| 6 |
28/3/2005 |
M/s. Blua Gross Lab Ltd., Mumbai |
M/s. Nergho Smart Dharno, China |
US$2500 |
|
| 7 |
28/3/2005 |
M/s. Glaxo Smithkline Ltd., Mumbai |
M/s. Glaxo Smithkline S.p.A Pharma, Italy |
US$3500 |
|
| 8 |
2/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Novartis Pharma, Switzerland |
US$15500 |
|
| 9 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Schering Plough S.A., Spain |
US$2500 |
|
| 10 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Fujan Fuhug Pharmaceuticals Co. Ltd., China |
US$3500 |
|
| 11 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Schering Plugh (Brchinf) Co., Ireland |
US$3500 |
|
| 12 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Centocor B.V., The Netherland |
US$2500 |
|
| 13 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. University of Towo, Towo |
US$2500 |
|
| 14 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Medimmuha Pharma B.V., The Netherland |
US$2500 |
|
| 15 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Schering Plough Products IIC, Puerto Roco |
US$2500 |
|
| 16 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Schering Plough Ltd., Republic of Singapore |
US$3500 |
|
| 17 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. Schering Plough (Avendole) Co., Ireland |
US$3500 |
|
| 18 |
29/3/2005 |
M/s. Fulford (I) Ltd., Mumbai |
M/s. ICN Czech Republic, Czech Republic |
US$2500 |
|
| 19 |
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Novartis Pharma Schneizerpalle, Switzerland |
US$3500 |
|
| 20 |
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Novartis Pharma SAS, France |
US$3500 |
|
| 21 |
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Novartis Farmaceutica SA, Spain |
US$2500 |
|
|
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Parhelala Pharmaceuticals Inc., USA |
US$2500 |
|
|
| 23 |
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. Novartis Pharma AG Basel, Switzerland |
US$6500 |
|
| 24 |
30/3/2005 |
M/s. Novartis India Ltd., Mumbai |
M/s. R.P. Scheror GmbH Co. K.G, Germany |
US$2500 |
|
| 25 |
30/3/2005 |
M/s. Roche Scientific Co. (I) Pvt. Ltd., Mumbai |
M/s. F. Hoffmann La Rocha Ltd., Basel Switzerland |
US$6500 |
|
| 26 |
30/3/2005 |
M/s. Roche Scientific Co. (I) Pvt. Ltd., Mumbai |
M/s. Hoffman La Roche Inc., New Jersy |
US$5500 |
|
| 27 |
30/3/2005 |
M/s. Roche Scientific Co. (I) Pvt. Ltd., Mumbai |
M/s. Gchentech Inc., California USA |
US$3500 |
|
| 28 |
30/3/2005 |
M/s. Roche Scientific Co. (I) Pvt. Ltd., Mumbai |
M/s. R.P. Scheres GmbH Co., Germany |
US$4500 |
|
| 29 |
30/3/2005 |
M/s. Roche Scientific Co. (I) Pvt. Ltd., Mumbai |
|
US$18000 |
|
| 30 |
30/3/2005 |
M/s. Fulford (I) Ltd., Mumabi |
M/s. Schering Plough Products LLC., USA |
US$2500 |
|
| 31 |
30/3/2005 |
M/s. Eli Lilly Co. (I) Pvt. Ltd. |
M/s. Centocor, Netherlands |
US$2500 |
|
| 32 |
30/3/2005 |
M/s. Eli Lilly Co. (I) Pvt. Ltd. |
M/s. Lilly Pharma, Germany |
US$3500 |
|
| 33 |
30/3/2005 |
M/s. Eli Lilly Co. (I) Pvt. Ltd. |
M/s. Lilly France SAS |
US$7500 |
|
| 34 |
30/3/2005 |
M/s. Eli Lilly Co. (I) Pvt. Ltd. |
M/s. Elli Lilly & Co., USA |
US$2500 |
|
| 35 |
23/3/2005 |
M/s. GSK |
M/s. Glaxo Operator Co. Ltd., UK |
US$3500 |
|
| 36 |
23/3/2005 |
M/s. GSK |
M/s. Glaxo Operatice Co. Ltd. |
US$8500 |
|
| 37 |
M/s. Glaxo Smithkline |
M/s. GSK, Australia |
US$3500 |
|
|
| 38 |
M/s. Esschem (P) Ltd., Mumbai |
M/s. Fermic SA, de CV, Mexico |
US$2500 |
|
|
| 39 |
31/3/2005 |
M/s. Baxter India P. Ltd. |
M/s. Baxter Healthcare Co. Ltd. |
US$2500 |
|
| 40 |
31/3/2005 |
M/s. Wyeth Ltd., Mumbai |
M/s. Ladorla Laboratories |
US$2500 |
|
| 41 |
31/3/2005 |
M/s. Wyeth Ltd., Mumbai |
M/s. Wyeth Ayerst Laderte Inc. USA |
US$3500 |
|